Challenges in the development of an autologous heat shock protein based anti-tumor vaccine.
about
Heat shock proteins: stimulators of innate and acquired immunityCancer vaccines: are we there yet?Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccinesA member of the HSP90 family from ovine Babesia in China: molecular characterization, phylogenetic analysis and antigenicity.Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer.Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potentialAutologous heat-shock protein vaccines
P2860
Q26829100-8DD83D81-3B46-41FA-8B39-A80E3FFDAB2CQ27012732-0C5E6F4C-040B-4395-A1DB-E5156C37F132Q28084299-A115174F-D8EF-470D-95FF-71109D459900Q30979343-6EDB393D-42CB-4DAA-A094-B03B1F37EA9CQ38095583-7F434348-0AAA-42D6-BB8A-FD3BBDA2EFBEQ38198491-E9222BE0-424B-42F9-94E7-A1E33F45AA62Q42815727-C0394450-8F77-4E0D-B9AB-A2309DF647DC
P2860
Challenges in the development of an autologous heat shock protein based anti-tumor vaccine.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges in the development ...... tein based anti-tumor vaccine.
@en
type
label
Challenges in the development ...... tein based anti-tumor vaccine.
@en
prefLabel
Challenges in the development ...... tein based anti-tumor vaccine.
@en
P2860
P356
P1476
Challenges in the development ...... tein based anti-tumor vaccine.
@en
P2093
Austin J Combest
Dirk J Reitsma
P2860
P304
P356
10.4161/HV.21382
P5008
P577
2012-08-01T00:00:00Z